Live Quote · AMEXPILLFinancial Services· Asset Management

Direxion Daily Pharmaceutical & Medical Bull 3X ETF

$18.43 7.59%(+$1.30)
TickerSpark Score

Limited financial coverage for PILL.

Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.

100
Momentum
52-Week Range98% of range
Low
$5.20
Current
$18.43
High
$18.68

About the company

PILL seeks to deliver investment results of 3x the daily performance of the S&P Pharmaceuticals Select Industry Index, a modified equal-weighted index that measures the performance of pharmaceutical companies, as defined by GICS, on the S&P Total Market Index. The fund uses derivatives and swaps to achieve its target exposure. As a levered product with daily resets, PILL is designed as a short-term trading tool and not a long-term investment vehicle.

CEO
Michael Davidson
IPO
2017
Employees
39
HQ
New York, NY, US

Price Chart

+238.79% · this period
$18.43$11.87$5.30Jul 02Dec 31Jul 02
Valuation
Market Cap
$38.21M
Div Yield
0.37%
Performance & Tape
52W High
$18.68
52W Low
$5.20
50D MA
$13.28
200D MA
$11.33
Beta
2.12
Avg Volume
67.30K

Get TickerSpark's AI analysis on PILL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Dec 13, 06FALK MICHAELother1,040,106
Dec 13, 06FALK MICHAELother67,233
Apr 16, 06FALK MICHAELother3,333
Aug 28, 06MCGUIRE JAMESother0
Sep 6, 05MCGUIRE JAMESother0
May 10, 05FALK MICHAELother148,433
Aug 1, 05FALK MICHAELother1,040,106
Dec 8, 04MCNAMARA KEVIN Mother75,000
Jan 18, 05MCNAMARA KEVIN Mother25,000
Dec 21, 04MCNAMARA KEVIN Mother75,000
Coverage · PILL

Our PILL coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PILL yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PILL report →
Internal Compare

Similar companies

Peers in the same neighborhood.